Drug
Orkambi
Orkambi is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
33%(1 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_4
1
25%
Ph phase_2
1
25%
Ph not_applicable
1
25%
Phase Distribution
0
Early Stage
1
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 2Efficacy & side effects
1(33.3%)
Phase 4Post-market surveillance
1(33.3%)
N/ANon-phased studies
1(33.3%)
Highest Phase Reached
Phase 4Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 4
Trials by Phase
Phase 21 (33.3%)
Phase 41 (33.3%)
N/A1 (33.3%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completednot_applicable
Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.
NCT03894657
completed
Orkambi Treatment in 2 to 5 Year Old Children With CF
NCT03795363
completedphase_2
A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
NCT02709109
terminatedphase_4
Functional Respiratory Imaging and Orkambi in CF
NCT03956589
Clinical Trials (4)
Showing 4 of 4 trials
NCT03894657Not Applicable
Validation of Respiratory Epithelial Functional Assessment to Predict Clinical Efficacy of Orkambi®.
NCT03795363
Orkambi Treatment in 2 to 5 Year Old Children With CF
NCT02709109Phase 2
A Study to Evaluate the Safety and Efficacy of VX-371 in Subjects With Cystic Fibrosis Who Are Homozygous for the F508del-CFTR Mutation
NCT03956589Phase 4
Functional Respiratory Imaging and Orkambi in CF
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4